PDF
ePub
Citation
Print
Abstract
We report two patients with relapsed urethral condyloma treated by interleukin-2 (IL-2) instillation. The patients had undergone prior treatment of the urethral condyloma; however, all patients had recurrent disease within one year of the primary treatment. We performed repeated transurethral resection of the urethra. However, the mass was incompletely resected due to its multiplicity and concerns about urethral injury. After surgery, IL-2 (18x106IU) mixed with 1.2ml of distilled water was equally divided into six units (3x106IU); 10ml of distilled water was mixed with each unit. The solution was then administered into the urethra. After 6 days of the IL-2 intraurethral treatment, no visible warts were noted. No recurrence has been observed in over 1 year of follow up.
REFERENCES
1.Debenedictis TJ., Marmar ML., Praiss DE. Intraurethral condylomas acuminata: management and review of the literature. J Urol. 1977. 118:767–9.
2.Bohle A., Doehn C., Kausch I., Jocham D. Treatment of recurrent penile condyloma acuminate with external application and intraurethral instillation of bacillus calmette-guerin. J Urol. 1998. 160:394–6.
3.Kim EK., Lee NK., Park YH. Detection of interleukin 2 in the urine of patients with superficial bladder tumors after intravesical BCG therapy. Korean J Urol. 1996. 37:1227–33.
4.Fralick RA., Malek RS., Goellner JR., Hyland KM. Urethroscopy and urethral cytology in men with external genital condyloma. Urology. 1994. 43:361–4.
5.Simmons PD., Langlet F., Thin RN. Cryotherapy versus electrocautery in the treatment of genital warts. Br J Vener Dis. 1981. 57:273–4.
6.Kim SG., Seo IY., Rim JS. Nd: YAG laser therapy for intraurethral condyloma acuminatum in men. Korean J Urol. 2003. 44:911–5.
7.Dretler SP., Klein LA. The eradication of intraurethral condyloma acuminata with 5 percent 5-fluorouracil cream. J Urol. 1975. 113:195–8.
8.Chopra V., Tyring SK. Suppression of interleukin-2 production and activity by factor (s) released by peripheral blood mononuclear cells during papillomavirus infections. Viral Immunol. 1991. 4:237–48.
9.Hamblin TJ. Long-lasting response of therapy-resistant viral warts to treatment with interleukin-2 in a patient with chronic lymphocytic leukemia (CLL) and profound immunodeficiency. Leuk Res. 2007. 31:413–4.
10.Kreft ME., Sterle M., Veranic P., Jezernik K. Urothelial injuries and the early wound healing response: tight junctions and urothelial cytodifferentiation. Histochem Cell Biol. 2005. 123:529–39.
XML Download